Extendicare (TSE:EXE)
TSX:EXE
Holding TSE:EXE?
Track your performance easily

Extendicare (EXE) Technical Analysis

166 Followers

Summary of all the Indicators

Overall Consensus
Buy
15Bullish
2Neutral
5Bearish
Technical Analysis Consensus
Sell
3Bullish
2Neutral
5Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Extendicare’s (EXE) Moving Averages Convergence Divergence (MACD) indicator is 0.07, suggesting Extendicare is a Sell.
Extendicare’s (EXE) 20-Day exponential moving average is 9.25, while Extendicare’s (EXE) share price is C$9.52, making it a Buy.
Extendicare’s (EXE) 50-Day exponential moving average is 9.02, while Extendicare’s (EXE) share price is C$9.52, making it a Buy.

Extendicare (EXE) Pivot Points

Nov 12, 2024, 08:47 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
9.17
9.24
9.32
9.39
9.47
9.54
9.62
Fibonacci
9.24
9.29
9.33
9.39
9.44
9.48
9.54
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Extendicare (EXE) Moving Averages

Nov 12, 2024, 08:47 PM
Period
Simple
Exponential
MA5
9.34Buy
9.39Buy
MA10
9.25Buy
9.30Buy
MA20
9.23Buy
9.25Buy
MA50
9.17Buy
9.02Buy
MA100
8.37Buy
8.56Buy
MA200
7.71Buy
7.91Buy
Extendicare’s (EXE) 10-Day exponential moving average is 9.30, while Extendicare’s (EXE) share price is C$9.52, making it a Buy.
Extendicare’s (EXE) 100-Day exponential moving average is 8.56, while Extendicare’s (EXE) share price is C$9.52, making it a Buy.
Extendicare’s (EXE) stock price is C$9.52 and Extendicare’s (EXE) 50-day simple moving average is 9.17, creating a Buy signal.
Extendicare’s (EXE) stock price is C$9.52 and Extendicare’s (EXE) 100-day simple moving average is 8.37, creating a Buy signal.
Extendicare’s (EXE) stock price is C$9.52 and Extendicare’s (EXE) 200-day simple moving average is 7.71, creating a Buy signal.

Extendicare (EXE) Technical Indicators

Nov 12, 2024, 08:47 PM
Name
Value
Implied Action
RSI (14)
66.79
Neutral
STOCH (9,6)
92.02
Sell
STOCHRSI (14)
92.02
Sell
MACD (12,26)
0.07
Sell
ADX (14)
18.67
Buy
Williams %R
-8.96
Sell
CCI (14)
234.66
Sell
ATR (14)
0.17
-
Ultimate Oscillator
62.34
Neutral
ROC
5.40
Buy
Extendicare’s (EXE) Relative Strength Index (RSI) is 66.79, creating a Neutral signal.
Extendicare’s (EXE) Trend Strength Indicator (ADX) is 18.67, creating a Buy signal.
Extendicare’s (EXE) Commodity Channel Index (CCI) is 234.66, creating a Sell signal.
Extendicare’s (EXE) Price Rate of Change (ROC) is 5.40, creating a Buy signal.

FAQ

Is EXE a Buy, Hold, or Sell?
Based on EXE’s technical indicators, EXE is a Buy.
    What is EXE’s RSI (14)?
    EXE’s RSI (14) is 66.79, which suggests EXE is a Neutral.
      What is EXE’s MACD?
      EXE’s MACD is 0.07, which suggests EXE is a Sell.
        What is EXE’s 5-day moving average?
        EXE’s 5-day moving average is 9.34, which suggests EXE is a Buy.
          What is EXE’s 20-day moving average?
          EXE 20-day moving average is 9.23, which suggests EXE is a Buy.
            What is EXE’s 50-day moving average?
            EXE’s 50-day moving average is 9.17, which suggests EXE is a Buy.
              What is EXE’s 200-day moving average?
              EXE’s 200-day moving average is 7.71, which suggests EXE is a Buy.
                What is EXE’s Williams % R (14)?
                EXE’s Williams % R (14) is -8.96, which suggests EXE is a Sell.
                  What is EXE’s CCI (14)?
                  EXE’s CCI (14) is 234.66, which suggests EXE is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis